Table 1 Baseline patient characteristics
Study site 1 | Study site 2 | |
|---|---|---|
n [eyes (patients)] | 278 (272) | 255 (252) |
Age [years; mean (± SD)] | 60.2 (± 10.2) | 61.1 (± 14.2) |
Sex [male; %] | 59.0 | 67.1 |
Vitrectomy | ||
23/25-gauge [eyes (%)] | 250 (89.9) | 241 (94.5) |
20-gauge [eyes (%)] | 28 (10.1) | 14 (5.5) |
Endotamponade | ||
C3F8 [eyes (%)] | 201 (72.3) | 1 (0.4) |
C2F6 [eyes (%)] | 53 (19.1) | 0 (0) |
C3F8 or C2F6 [eyes (%)] | 254 (91.4) | 1 (0.4) |
SF6 [eyes (%)] | 6 (2.2) | 246 (96.5) |
Silicone oil [eyes (%)] | 18 (6.5) | 8 (3.1) |